Endocrine manifestations related to inherited metabolic diseases in adults

Orphanet Journal of Rare Diseases

Volumn 7, Issue 1, 2012, Pages

  Vantyghem, Marie Christine ^a   Dobbelaere, Dries ^a   Mention, Karine ^a   Wemeau, Jean Louis ^a   Saudubray, Jean Marie ^b   Douillard, Claire ^a  

^a UNIV LILLE   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

adrenal failure; diabetes mellitus; endocrine dysfunction; hypogonadism; hypoparathyroidism; hypopituitarism; Inborn errors of metabolism; thyroid dysfunction

Indexed keywords

ALPHA GLUCOSIDASE INHIBITOR; INDOMETACIN; INSULIN; MERCAPTAMINE; SULFONYLUREA; THIAMINE; UBIDECARENONE;

ACIDURIA; ADRENAL INSUFFICIENCY; ADULT; ALSTROM SYNDROME; BONE METABOLISM; CHANNELOPATHY; CYSTINOSIS; DIABETES MELLITUS; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENDOCRINE DISEASE; ENERGY METABOLISM; ENZYME REPLACEMENT; FABRY DISEASE; GALACTOSEMIA; GENE THERAPY; GLYCOGEN STORAGE DISEASE; HEMOCHROMATOSIS; HEREDITARY ACOERULOPLASMINEMIA; HEREDITARY HEMOCHROMATOSIS; HUMAN; HYPOGONADISM; HYPOGONADOTROPIC HYPOGONADISM; HYPOPARATHYROIDISM; HYPOPITUITARISM; INBORN ERROR OF METABOLISM; INSULIN TREATMENT; IRON CHELATION; LIPIDOSIS; MEGALOBLASTIC ANEMIA; ORGANIC ACIDURIA; OXALOSIS 1; PHLEBOTOMY; REVIEW; THYROID DISEASE; VITAMIN SUPPLEMENTATION; ENDOCRINE GLAND; GENETICS; PATHOPHYSIOLOGY;

ADULT; ENDOCRINE GLANDS; HUMANS; METABOLISM, INBORN ERRORS;

EID: 84856157291     PISSN: None     EISSN: 17501172     Source Type: Journal    
DOI: 10.1186/1750-1172-7-11     Document Type: Review

References (132)

1. Inborn errors of metabolism in adults. Saudubray JM, Sedel F, Ann Endocrinol (Paris) 2009 70 14 24 10.1016/j.ando.2008.12.004
2. Molecular diagnosis of genetic iron-overload disorders. Brissot P, Bardou-Jacquet E, Troadec MB, Mosser A, Island ML, Detivaud L, Loréal O, Jouanolle AM, Expert Rev Mol Diagn 2010 10 755 763 10.1586/erm.10.55 20843199
3. Phenotype and HFE genotype in a population with abnormal iron markers recruited from an Endocrinology Department. Vantyghem MC, Fajardy I, Dhondt F, Girardot C, D'Herbomez M, Danze PM, Rousseaux J, Wemeau JL, Eur J Endocrinol 2006 154 835 841 10.1530/eje.1.02152 16728543 (Pubitemid 43997722)
4. Criteria for early identification of aceruloplasminemia. Ogimoto M, Anzai K, Takenoshita H, Kogawa K, Akehi Y, Yoshida R, Nakano M, Yoshida K, Ono J, Intern Med 2011 50 1415 1418 10.2169/internalmedicine.50.5108 21720062
5. Aceruloplasminemia: a novel mutation in a family with marked phenotypic variability. Fasano A, Colosimo C, Miyajima H, Tonali PA, Re TJ, Bentivoglio AR, Mov Disord 2008 23 751 755 10.1002/mds.21938 18200628
6. MELAS: A nationwide prospective cohort study of 96 patients in Japan. Yatsuga S, Povalko N, Nishioka J, Katayama K, Kakimoto N, Matsuishi T, Kakuma T, Koga Y, Taro Matsuoka for MELAS Study Group in Japan, Biochim Biophys Acta 2011
7. Mitochondria and diabetes mellitus: unstangling a conflictive relationship? Schiff M, Loublier S, Coulibaly A, Benit P, Ogier de Bauny H, Rustin P, J Inher Metab Dis 2009 32 684 698 10.1007/s10545-009-1263-0 19821144
8. Endocrine disorders in two sisters affected by MELAS syndrome. Balestri P, Grosso S, J Child Neurol 2000 15 755 758 10.1177/088307380001501108 11108510 (Pubitemid 32057420)
9. Sequence homology at the breakpoint and clinical phenotype of mitochondrial DNA deletion syndromes. Sadikovic B, Wang J, El-Hattab A, Landsverk M, Douglas G, Brundage EK, Craigen WJ, Schmitt ES, Wong LJ, PLoS One 2010 5 12 15687 10.1371/journal.pone.0015687 21187929
10. Retinal and renal complications in patients with a mutation of mitochondrial DNA at position 3,243 (maternally inherited diabetes and deafness) A case-control study. Massin P, Dubois-Laforgue D, Meas T, Laloi-Michelin M, Gin H, Bauduceau B, Bellanné-Chantelot C, Bertin E, Blickle JF, Bouhanick B, Cahen-Varsaux J, Casanova S, Charpentier G, Chedin P, Dupuy O, Grimaldi A, Guerci B, Kaloustian E, Lecleire-Collet A, Lorenzini F, Murat A, Narbonne H, Olivier F, Paquis-Flucklinger V, Virally M, Vincenot M, Vialettes B, Timsit J, Guillausseau PJ, GEDIAM (Mitochondrial Diabetes French Study Group), Diabetologia 2008 51 1664 1670 10.1007/s00125-008-1073-1 18581092
11. In situ characterization of islets in diabetes with a mitochondrial DNA mutation at nucleotide position 3243. Kobayashi T, Nakanishi K, Nakase H, Kajio H, Okubo M, Murase T, Kosaka K, Diabetes 1997 46 1567 1571 10.2337/diabetes.46. 10.1567 9313751 (Pubitemid 27411231)
12. Role of the Mitochondria in Immune-Mediated Apoptotic Death of the Human Pancreatic Cell Line Lox5. Lightfoot YL, Chen J, Mathews CE, PLoS One 2011 6 20617 10.1371/journal.pone.0020617 21738580
13. Pancreatic -cell secretory defect associated with mitochondrial point mutation of the tRNA (LEU(UUR)) gene: a study in seven families with mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS). Suzuki S, Hinokio Y, Hirai S, Onoda M, Matsumoto M, Ohtomo M, Kawasaki H, Satoh Y, Akai H, Abe K, and al, Diabetologia 1994 37 818 825 10.1007/BF00404339 7988784
14. Intracellular ATP directly blocks K+ channels in pancreatic B-cells. Cook DL, Hales CN, Nature 1984 311 271 273 10.1038/311271a0 6090930 (Pubitemid 14071146)
15. The m.3243A > G mutation in mitochondrial DNA leads to decreased insulin sensitivity in skeletal muscle and to progressive -cell dysfunction. Lindroos MM, Majamaa K, Tura A, Mari A, Kalliokoski KK, Taittonen MT, Iozzo P, Nuutila P, Diabetes 2009 58 543 549 19073775
16. Mitochondrial Diabetes French Study Group: The clinical variability of maternally inherited diabetes and deafness is associated with the degree of heteroplasmy in blood leukocytes. Laloi-Michelin M, Meas T, Ambonville C, Bellanné-Chantelot C, Beaufils S, Massin P, Vialettes B, Gin H, Timsit J, Bauduceau B, Bernard L, Bertin E, Blickle JF, Cahen-Varsaux J, Cailleba A, Casanova S, Cathebras P, Charpentier G, Chedin P, Crea T, Delemer B, Dubois-Laforgue D, Duchemin F, Ducluzeau PH, Bouhanick B, Dusselier L, Gabreau T, Grimaldi A, Guerci B, Jacquin V, Kaloustian E, Larger E, Lecleire-Collet A, Lorenzini F, Louis J, Mausset J, Murat A, Nadler-Fluteau S, Olivier F, Paquis-Flucklinger V, Paris-Bockel D, Raynaud I, Reznik Y, Riveline JP, Schneebeli S, Sonnet E, Sola-Gazagnes A, Thomas JL, Trabulsi B, Virally M, Guillausseau PJ, J Clin Endocrinol Metab 2009 94 3025 3030 10.1210/jc.2008-2680 19470619
17. Correction of the consequences of mitochondrial 3243A > G mutation in the MT-TL1 gene causing the MELAS syndrome by tRNA import into mitochondria. Karicheva OZ, Kolesnikova OA, Schirtz T, Vysokikh MY, Mager-Heckel AM, Lombès A, Boucheham A, Krasheninnikov IA, Martin RP, Entelis N, Tarassov I, Nucleic Acids Res 2011 39 8173 86 10.1093/nar/gkr546 21724600
18. The mitochondrial ND1 m.3337G > A mutation associated to multiple mitochondrial DNA deletions in a patient with Wolfram syndrome and cardiomyopathy. Mezghani N, Mnif M, Mkaouar-Rebai E, Kallel N, Salem IH, Charfi N, Abid M, Fakhfakh F, Biochem Biophys Res Commun 2011 411 247 52 10.1016/j.bbrc.2011.06.106 21723259
19. Mutational spectrum of the WFS1 gene in Wolfram syndrome, nonsyndromic hearing impairment, diabetes mellitus, and psychiatric disease. Cryns K, Sivakumaran TA, Van den Ouweland JM, Pennings RJ, Cremers CW, Flothmann K, Young TL, Smith RJ, Lesperance MM, Van Camp G, Hum Mutat 2003 22 275 287 10.1002/humu.10258 12955714 (Pubitemid 37210853)
20. Sex differences in the development of diabetes in mice with deleted wolframin (WFS1) gene. Noormets K, Kks S, Muldmaa M, Mauring L, Vasar E, Tillmann V, Exp Clin Endocrinol Diabetes 2011 119 271 275 10.1055/s-0030-1265163 21031341
21. Mutations in the ABCC8 gene can cause autoantibody-negative insulin-dependent diabetes. Hartemann-Heurtier A, Simon A, Bellanné- Chantelot C, Reynaud R, Cavé H, Polak M, Vaxillaire M, Grimaldi A, Diabetes Metab 2009 35 233 235 10.1016/j.diabet.2009.01.003 19342262
22. Mutations in the ABCC8 (SUR1 subunit of the K(ATP) channel) gene are associated with a variable clinical phenotype. Klupa T, Kowalska I, Wyka K, Skupien J, Patch AM, Flanagan SE, Noczynska A, Arciszewska M, Ellard S, Hattersley AT, Sieradzki J, Mlynarski W, Malecki MT, Clin Endocrinol (Oxf) 2009 71 358 362 10.1111/j.1365-2265.2008.03478.x
23. Hyperinsulinaemic hypoglycaemia and diabetes mellitus due to dominant ABCC8/KCNJ11 mutations. Kapoor RR, Flanagan SE, James CT, McKiernan J, Thomas AM, Harmer SC, Shield JP, Tinker A, Ellard S, Hussain K, Diabetologia 2011 54 2575 83 10.1007/s00125-011-2207-4 21674179
24. Impaired glucose tolerance and predisposition to the fasted state in liver glycogen synthase knock-out mice. Irimia JM, Meyer CM, Peper CL, Zhai L, Bock CB, Previs SF, McGuinness OP, DePaoli-Roach A, Roach PJ, J Biol Chem 2010 285 12851 12861 10.1074/jbc.M110.106534 20178984
25. Secondary diabetes mellitus: late complication of glycogen storage disease type 1b. Spiegel R, Rakover-Tenenbaum Y, Mandel H, Lumelski D, Admoni O, Horovitz Y, J Pediatr Endocrinol Metab 2005 18 617 619 10.1515/JPEM.2005.18.6. 617 16042332 (Pubitemid 40916493)
26. Diabetes mellitus secondary to glycogen storage disease type III. Oki Y, Okubo M, Tanaka S, Nakanishi K, Kobayashi T, Murase T, Diabet Med 2000 17 810 812 10.1046/j.1464-5491.2000.00378.x 11131107 (Pubitemid 32000981)
27. Glycogen storage disease type III presenting with secondary diabetes and managed with insulin: a case report. Ismail H, Cases J 2009 2 6891 10.4076/1757-1626-2-6891 19829878
28. New Alström syndrome phenotypes based on the evaluation of 182 cases. Marshall JD, Bronson RT, Collin GB, Nordstrom AD, Maffei P, Paisey RB, Carey C, Macdermott S, Russell-Eggitt I, Shea SE, Davis J, Beck S, Shatirishvili G, Mihai CM, Hoeltzenbein M, Pozzan GB, Hopkinson I, Sicolo N, Naggert JK, Nishina PM, Arch Intern Med 2005 165 675 683 10.1001/archinte.165.6.675 15795345 (Pubitemid 40393151)
29. Presentation and course of diabetes in children and adolescents with Alstrom syndrome. Mokashi A, Cummings EA, Pediatr Diabetes 2011 12 3 Pt 2 270 275 21518413
30. The progression from obesity to type 2 diabetes in Alström syndrome. Bettini V, Maffei P, Pagano C, Romano S, Milan G, Favaretto F, Marshall JD, Paisey R, Scolari F, Greggio NA, Tosetto I, Naggert JK, Sicolo N, Vettor R, Pediatr Diabetes 2011 doi: 10.1111/j.1399-5448.2011.00789.x
31. Alström syndrome: insights into the pathogenesis of metabolic disorders. Girard D, Petrovsky N, Nat Rev Endocrinol 2011 7 77 88 10.1038/nrendo.2010.210 21135875
32. Slowly deteriorating insulin secretion and C-peptide production characterizes diabetes mellitus in infantile cystinosis. Filler G, Amendt P, von Bredow MA, Rohde W, Ehrich JH, Eur J Pediatr 1998 157 738 742 10.1007/s004310050926 9776533 (Pubitemid 28419102)
33. Nephropathic cystinosis in adults: natural history and effects of oral cysteamine therapy. Gahl WA, Balog JZ, Kleta R, Ann Intern Med 2007 147 242 250 17709758 (Pubitemid 351664580)
34. Growth retardation in children with cystinosis. Besouw M, Levtchenko E, Minerva Pediatr 2010 62 307 314 20467383
35. Insights into novel cellular injury mechanisms by gene expression profiling in nephropathic cystinosis. Sansanwal P, Li L, Hsieh SC, Sarwal MM, J Inherit Metab Dis 2010 33 775 786 10.1007/s10545-010-9203-6 20865335
36. Thiamine-responsive megaloblastic anemia syndrome: long-term follow-up. Borgna-Pignatti C, Azzalli M, Pedretti S, J Pediatr 2009 155 295 297 10.1016/j.jpeds.2009.01.062 19619756
37. Diabetic ketoacidosis revealing thimine responsive megaloblastic anemia. Bouyahia 0, Ouderni M, Ben Mansour F, Matoussi N, Khaldi F, Ann Endocrinol (Paris) 2009 70 477 479 10.1016/j.ando.2009.09.001
38. Thiamine transporter mutation: an example of monogenic diabetes mellitus. Alzahrani AS, Baitei E, Zou M, Shi Y, Eur J Endocrinol 2006 155 787 792 10.1530/eje.1.02305 17132746 (Pubitemid 46040615)
39. Chronic intermittent form of isovaleric acidemia mimicking diabetic ketoacidosis. Erdem E, Cayonu N, Uysalol E, Yildirmak ZY, J Pediatr Endocrinol Metab 2010 23 503 505 10.1515/jpem.2010.082 20662350
40. Chronic pancreatitis in branched-chain organic acidurias-a case of methylmalonic aciduria and an overview of the literature. Marquard J, El Scheich T, Klee D, Schmitt M, Meissner T, Mayatepek E, Oh J, Eur J Pediatr 2011 170 241 245 10.1007/s00431-010-1313-5 20924605
41. Mitochondrial dysfunction and organic aciduria in five patients carrying mutations in the Ras-MAPK pathway. Kleefstra T, Wortmann SB, Rodenburg RJ, Bongers EM, Hadzsiev K, Noordam C, van den Heuvel LP, Nillesen WM, Hollody K, Gillessen-Kaesbach G, Lammens M, Smeitink JA, van der Burgt I, Morava E, Eur J Hum Genet 2011 19 138 144 10.1038/ejhg.2010.171 21063443
42. Thyroid function and human reproductive health. Krassas GE, Poppe K, Glinoer D, Endocr Rev 2010 31 702 755 10.1210/er.2009-0041 20573783
43. The potential repercussions of maternal, fetal, and neonatal hypothyroxinemia on the progeny. Glinoer D, Delange F, Thyroid 2000 10 871 887 10.1089/thy.2000.10.871 11081254
44. The effect of maternal hypothyroidism on the carbohydrate metabolism and insulin secretion of isolated islets in adult male offspring of rats. Farahani H, Ghasemi A, Roghani M, Zahediasl S, Horm Metab Res 2010 42 792 797 10.1055/s-0030-1262826 20730704
45. Endocrine dysfunction in Kearns-Sayre syndrome. Harvey JN, Barnett D, Clin Endocrinol (Oxf) 1992 37 97 103 10.1111/j.1365-2265.1992.tb02289.x
46. MELAS- and Kearns-Sayre-type co-mutation with myopathy and autoimmune polyendocrinopathy. Ohno K, Yamamoto M, Engel AG, Harper CM, Roberts LR, Tan GH, Fatourechi V, Ann Neurol 1996 39 761 766 10.1002/ana.410390612 8651648 (Pubitemid 26183812)
47. A novel mutation in the mitochondrial 16S rRNA gene in a patient with MELAS syndrome, diabetes mellitus, hyperthyroidism and cardiomyopathy. Hsieh RH, Li JY, Pang CY, Wei YH, J Biomed Sci 2001 8 328 335 10.1007/BF02258374 11455195
48. Multisystem disorder in late-onset chronic progressive external ophthalmoplegia. Pfeffer G, Sirrs S, Wade NK, Mezei MM, Can J Neurol Sci 2011 38 119 123 21156440
49. Increased prevalence of thyroid autoimmunity and hypothyroidism in patients with glycogen storage disease type I. Melis D, Pivonello R, Parenti G, Della Casa R, Salerno M, Lombardi G, Sebastio G, Colao A, Andria G, J Pediatr 2007 15 300 305
50. High prevalence of subclinical hypothyroidism in patients with Anderson-Fabry disease. Hauser AC, Gessl A, Lorenz M, Voigtländer T, Födinger M, Sunder-Plassmann G, J Inherit Metab Dis 2005 28 715 722 10.1007/s10545-005-0003-3 16151903 (Pubitemid 41349259)
51. Endocrine dysfunction in patients with Fabry disease. Faggiano A, Pisani A, Milone F, Gaccione M, Filippella M, Santoro A, Vallone G, Tortora F, Sabbatini M, Spinelli L, Lombardi G, Cianciaruso B, Colao A, J Clin Endocrinol Metab 2006 91 4319 4325 10.1210/jc.2006-0858 16926253 (Pubitemid 44833405)
52. Thyroid function in Fabry disease before and after enzyme replacement therapy. Faggiano A, Severino R, Ramundo V, Russo R, Vuolo L, Del Prete M, Marciello F, Lombardi G, Cianciaruso B, Colao A, Pisani A, Minerva Endocrinol 2011 36 1 5 21460782
53. Genotype-phenotype correlation in primary hyperoxaluria type 1: the pGly170Arg AGXT mutation is associated with a better outcome. Harambat J, Fargue S, Acquaviva C, Gagnadoux MF, Janssen F, Liutkus A, Mourani C, Macher MA, Abramowicz D, Legendre C, Durrbach A, Tsimaratos M, Nivet H, Girardin E, Schott AM, Rolland MO, Cochat P, Kidney Int 2010 77 443 449 10.1038/ki.2009.435 20016466
54. Hypothyroidism in primary hyperoxaluria type 1. Frishberg Y, Feinstein S, Rinat C, Drukker A, J Pediatr 2000 136 255 257 10.1016/S0022-3476(00)70112-0 10657836 (Pubitemid 30471001)
55. Late-onset primary hyperoxaluria triggered by hypothyroidism and presenting as rapidly progressive renal failure - description of a new mutation. Tintillier M, Pochet JM, Cosyns JP, Delgrange E, Donckier J, Clin Nephrol 2004 62 155 157 15356974 (Pubitemid 39162769)
56. State of the art in muscle lipid diseases. Liang WC, Nishino I, Acta Myol 2010 29 351 6 21314018
57. Clear cells detection in nodular thyroid disease is not always indicative of neoplasia: description of the first case of thyroid involvement in multisystem triglyceride storage disease. Benelli E, Fiore E, Giustarini E, Romani R, Pennisi E, Pinchera A, Giani C, Thyroid 2008 18 1001 1003 10.1089/thy.2007.0228 18788920
58. MCT8 mutation analysis and identification of the first female with Allan-Herndon-Dudley syndrome due to loss of MCT8 expression. Frints SG, Lenzner S, Bauters M, Jensen LR, Van Esch H, des Portes V, Moog U, Macville MV, van Roozendaal K, Schrander-Stumpel CT, Tzschach A, Marynen P, Fryns JP, Hamel B, van Bokhoven H, Chelly J, Beldjord C, Turner G, Gecz J, Moraine C, Raynaud M, Ropers HH, Froyen G, Kuss AW, Eur J Hum Genet 2008 16 1029 37 10.1038/ejhg.2008.66 18398436
59. Monocarboxylate transporter 8 deficiency: altered thyroid morphology and persistent high T3/T4 ratio after thyroidectomy. Wirth EK, Sheu SY, Chiu-Ugalde J, Sapin R, Klein M, Mossbrugger I, Quintanilla-Martinez L, Hrabé de Angelis M, Krude H, Riebel T, Rothe K, Köhrle J, Schmid KW, Schweizer U, Grüters A, Eur J Endocrinol 2011 165 555 61 10.1530/EJE-11-0369 21813593
60. Pregnancy in women heterozygous for MCT8 mutations: risk of maternal hypothyroxinemia and fetal care. Ramos HE, Morandini M, Carré A, Tron E, Floch C, Mandelbrot L, Neri N, De Sarcus B, Simon A, Bonnefont JP, Amiel J, Desguerre I, Valayannopoulos V, Castanet M, Polak M, Eur J Endocrinol 2011 164 309 314 10.1530/EJE-10-0679 21098685
61. Beneficial effects of propylthiouracil plus L-thyroxine treatment in a patient with a mutation in MCT8. Wémeau JL, Pigeyre M, Proust-Lemoine E, d'Herbomez M, Gottrand F, Jansen J, Visser TJ, Ladsous M, J Clin Endocrinol Metab 2008 93 2084 2088 10.1210/jc.2007-2719 18334584 (Pubitemid 351831519)
62. New disorders in carbohydrate metabolism: congenital disorders of glycosylation and their impact on the endocrine system. Miller BS, Freeze HH, Rev Endocr Metab Disord 2003 4 103 113 10.1023/A:1021883605280 12618564 (Pubitemid 36182155)
63. Mutations in the selenocysteine insertion sequence-binding protein 2 gene lead to a multisystem selenoprotein deficiency disorder in humans. Schoenmakers E, Agostine M, Mitchell C, Schoenmakers N, Papp L, Rajanayagam O, Padidela R, Ceron-Gutierrez L, Doffinger R, Prevosto C, Luan J, Montano S, Lu J, Castanet M, Clemons N, Groeneveld M, Castets P, Karbaschi M, Aitken S, Dixon A, Williams J, Campi I, Blount M, Burton H, Muntoni F, O'Donovan D, Dean A, Warren A, Brierley C, Baguley D, Guicheney P, Fitzgerald R, Coles A, Gaston H, Todd P, Holmgren A, Khanna KK, Cooke M, Semple R, Halsall D, Wareham N, Schwabe J, Grasso L, Beck-Peccoz P, Ogunko A, Dattani M, Gurnell M, Chatterjee K, J Clin Invest 2010 120 4220 4235 10.1172/JCI43653 21084748
64. Inherited defects of thyroid hormone metabolism. Dumitrescu AM, Refetoff S, Ann Endocrinol (Paris) 2011 72 95 98 10.1016/j.ando.2011.03.011
65. Selenium supplementation fails to correct the selenoprotein synthesis defect in subjects with SBP2 gene mutations. Schomburg L, Dumitrescu AM, Liao XH, Bin-Abbas B, Hoeflich J, Köhrle J, Refetoff S, Thyroid 2009 19 277 281 10.1089/thy.2008.0397 19265499
66. Secondary hypothyroidism in hereditary hemochromatosis: recovery after iron depletion. Hudec M, Grigerova M, Walsh CH, Thyroid 2008 18 255 257 10.1089/thy.2007.0140 18205549 (Pubitemid 351271524)
67. Hemochromatosis and Iron Overload Screening Study Research Investigators Thyroid-stimulating hormone and free thyroxine levels in persons with HFE C282Y homozygosity, a common hemochromatosis genotype: the HEIRS study. Barton JC, Leiendecker-Foster C, Reboussin DM, Adams PC, Acton RT, Eckfeldt JH, Thyroid 2008 18 831 838 10.1089/thy.2008.0091 18651828
68. Hypogonadism in hereditary hemochromatosis. McDermott JH, Walsh CH, J Clin Endocrinol Metab 2005 90 2451 2455 10.1210/jc.2004-0980 15657376 (Pubitemid 40586299)
69. Association between iron overload and osteoporosis in patients with hereditary hemochromatosis. Valenti L, Varenna M, Fracanzani AL, Rossi V, Fargion S, Sinigaglia L, Osteoporos Int 2009 20 549 555 10.1007/s00198-008-0701- 4 18661088
70. Three patients with middle-age-onset hemochromatosis caused by novel mutations in the hemojuvelin gene. Koyama C, Hayashi H, Wakusawa S, Ueno T, Yano M, Katano Y, Goto H, Kidokoro R, J Hepatol 2005 43 740 742 10.1016/j.jhep.2005. 06.024 16099526 (Pubitemid 41253245)
71. The impact of hemochromatosis mutations and transferrin genotype on gonadotropin serum levels in infertile men. Bureti-Tomljanovi A, Vlasteli I, Radojci Badovinac A, Starcevi-Cizmarevi N, Nadalin S, Risti S, Fertil Steril 2009 91 1793 1800 10.1016/j.fertnstert.2008.02.129 18395717
72. Sex hormones and risk of liver tumor. Giannitrapani L, Soresi M, La Spada E, Cervello M, D'Alessandro N, Montalto G, Ann N Y Acad Sci 2006 1089 228 236 10.1196/annals.1386.044 17261770 (Pubitemid 47092098)
73. The adult galactosemic phenotype. Waisbren SE, Potter NL, Gordon CM, Green RC, Greenstein P, Gubbels CS, Rubio-Gozalbo E, Schomer D, Welt C, Anastasoaie V, D'Anna K, Gentile J, Guo CY, Hecht L, Jackson R, Jansma BM, Li Y, Lip V, Miller DT, Murray M, Power L, Quinn N, Rohr F, Shen Y, Skinder-Meredith A, Timmers I, Tunick R, Wessel A, Wu BL, Levy H, Elsas L, Berry GT, J Inherit Metab Dis 2011
74. Gonadal function in male and female patients with classic galactosemia. Rubio-Gozalbo ME, Gubbels CS, Bakker JA, Menheere PP, Wodzig WK, Land JA, Hum Reprod Update 2010 16 177 188 10.1093/humupd/dmp038 19793842
75. Fertility and impact of pregnancies on the mother and child in classic galactosemia. Gubbels CS, Land JA, Rubio-Gozalbo ME, Obstet Gynecol Surv 2008 63 334 343 10.1097/OGX.0b013e31816ff6c5 18419833 (Pubitemid 351595142)
76. Pathophysiology of impaired ovarian failure in galactosemia. Forges T, Monnier-Barbarino P, Leheup B, Jouvet P, Hum Reprod Update 2006 12 573 584 10.1093/humupd/dml031 16835432 (Pubitemid 44307834)
77. FSH isoform pattern in classic galactosemia. Gubbels CS, Thomas CM, Wodzig WK, Olthaar AJ, Jaeken J, Sweep FC, Rubio-Gozalbo ME, J Inherit Metab Dis 2011 34 387 390 10.1007/s10545-010-9180-9 20814826
78. The endocrine system in treated patients with classical galactosemia. Rubio-Gozalbo ME, Panis B, Zimmermann LJ, Spaapen LJ, Menheere PP, Mol Genet Metab 2006 89 316 322 10.1016/j.ymgme.2006.07.005 16935538 (Pubitemid 44692539)
79. Early diagnosis of inherited metabolic disorders towards improving outcome: the controversial issue of galactosaemia. Schweitzer-Krantz S, Eur J Pediatr 2003 162 Suppl 1 50 S53 14614623
80. X-linked adrenoleukodystrophy: ABCD1 de novo mutations and mosaicism. Wang Y, Busin R, Reeves C, Bezman L, Raymond G, Toomer CJ, Watkins PA, Snowden A, Moser A, Naidu S, Bibat G, Hewson S, Tam K, Clarke JT, Charnas L, Stetten G, Karczeski B, Cutting G, Steinberg S, Mol Genet Metab 2011 104 160 6 10.1016/j.ymgme.2011.05.016 21700483
81. Early diagnosis of cerebral X-linked adrenoleukodystrophy in boys with Addison's disease improves survival and neurological outcomes. Polgreen LE, Chahla S, Miller W, Rothman S, Tolar J, Kivisto T, Nascene D, Orchard PJ, Petryk A, Eur J Pediatr 2011 170 1049 1054 10.1007/s00431-011-1401-1 21279382
82. Signs of testicular insufficiency in adrenomyeloneuropathy and neurologically asymptomatic X-linked adrenoleukodystrophy: a retrospective study. Assies J, Gooren LJ, Van Geel B, Barth PG, Int J Androl 1997 20 315 321 10.1046/j.1365-2605.1997.00066.x 16130276 (Pubitemid 28025224)
83. Rapid decline of fertility in a case of adrenoleukodystrophy. Aversa A, Palleschi S, Cruccu G, Silvestroni L, Isidori A, Fabbri A, Hum Reprod 1998 13 2474 2479 10.1093/humrep/13.9.2474 9806270 (Pubitemid 28451226)
84. Antioxidants halt axonal degeneration in a mouse model of X-adrenoleukodystrophy. Lápez-Erauskin J, Fourcade S, Galino J, Ruiz M, Schlüter A, Naudi A, Jove M, Portero-Otin M, Pamplona R, Ferrer I, Pujol A, Ann Neurol 2011 70 84 92 10.1002/ana.22363 21786300
85. Genetic classification and mutational spectrum of more than 600 patients with a Zellweger syndrome spectrum disorder. Ebberink MS, Mooijer PA, Gootjes J, Koster J, Wanders RJ, Waterham HR, Hum Mutat 2011 32 59 69 10.1002/humu.21388 21031596
86. Autosomal recessive cerebellar ataxia caused by mutations in the PEX2 gene. Sevin C, Ferdinandusse S, Waterham HR, Wanders RJ, Aubourg P, Orphanet J Rare Dis 2011 6 8 10.1186/1750-1172-6-8 21392394
87. Mutations in the DBP-deficiency protein HSD17B54 cause ovarian dysgenesis, hearing loss, and ataxia of Perrault syndrome. Pierce SB, Walsh T, Chisholm KM, Lee MK, Thornton AM, Fiumara A, Opitz JM, Levy-Lahad E, Klevit RE, King MC, Am J Hum Genet 2010 87 282 288 10.1016/j.ajhg.2010.07.007 20673864
88. Mutations in mitochondrial histidyl tRNA synthetase HARS2 cause ovarian dysgenesis and sensorineural hearing loss of Perrault syndrome. Pierce SB, Chisholm KM, Lynch ED, Lee MK, Walsh T, Opitz JM, Li W, Klevit RE, King MC, Proc Natl Acad Sci USA 2011 108 6543 6548 10.1073/pnas.1103471108 21464306
89. Congenital disorders of glycosylation (CDG): it's (nearly) all in it! Jaeken J, J Inherit Metab Dis 2011 34 853 858 10.1007/s10545-011-9299-3 21384229
90. Expression analysis revealing destabilizing mutations in phosphomannomutase 2 deficiency (PMM2-CDG): Expression analysis of PMM2-CDG mutations. Vega AI, Pérez-Cerdá C, Abia D, Gámez A, Briones P, Artuch R, Desviat LR, Ugarte M, Pérez B, J Inherit Metab Dis 2011 34 929 939 10.1007/s10545-011-9328-2 21541725
91. Nijmegen paediatric CDG rating scale: a novel tool to assess disease progression. Achouitar S, Mohamed M, Gardeitchik T, Wortmann SB, Sykut-Cegielska J, Ensenauer R, de Baulny HO, Ounap K, Martinelli D, de Vries M, McFarland R, Kouwenberg D, Theodore M, Wijburg F, Grünewald S, Jaeken J, Wevers RA, Nijtmans L, Elson J, Morava E, J Inherit Metab Dis 2011 4 923 927
92. Fibrotic response in fibroblasts from congenital disorders of glycosylation. Lecca MR, Maag C, Berger EG, Hennet T, J Cell Mol Med 2011 15 1788 1796 10.1111/j.1582-4934.2010.01187.x 21029365
93. Endocrinology of the carbohydrate-deficient glycoprotein syndrome type 1 from birth through adolescence. De Zegher F, Jaeken J, Pediatr Res 1995 37 4 Pt 1 395 401 7596677
94. Gonadal function and glycoprotein hormones in the carbohydrate-deficient glycoprotein (CDG) syndrome. Kristiansson B, Stibler H, Wide L, Acta Paediatr 1995 84 655 659 10.1111/j.1651-2227.1995.tb13720.x 7670249
95. Clinical features in adults with congenital disorders of glycosylation type Ia (CDG-Ia). Krasnewich D, O'Brien K, Sparks S, Am J Med Genet C Semin Med Genet 2007 145C 302 306 10.1002/ajmg.c.30143 17639595 (Pubitemid 47291940)
96. Congenital disorder of glycosylation type 1a: three siblings with a mild neurological phenotype. Coman D, McGill J, MacDonald R, Morris D, Klingberg S, Jaeken J, Appleton D, J Clin Neurosc 2007 14 668 672 10.1016/j.jocn.2006.04.008 (Pubitemid 46795563)
97. Congenital disorder of glycosylation type Ia presenting as early-onset cerebellar ataxia in an adult. Schoffer KL, O'Sullivan JD, McGill J, Mov Disord 2006 21 869 872 10.1002/mds.20804 16482534 (Pubitemid 44028313)
98. Pubertal development in ALG6 deficiency (congenital disorder of glycosylation type Ic). Miller BS, Freeze HH, Hoffmann GF, Sarafoglou K, Mol Genet Metab 2011 103 101 103 10.1016/j.ymgme.2011.01.016 21334936
99. Potent, selective, and orally available benzoisothiazolone phosphomannose isomerase inhibitors as probes for congenital disorder of glycosylation Ia. Dahl R, Bravo Y, Sharma V, Ichikawa M, Dhanya RP, Hedrick M, Brown B, Rascon J, Vicchiarelli M, Mangravita-Novo A, Yang L, Stonich D, Su Y, Smith LH, Sergienko E, Freeze HH, Cosford ND, J Med Chem 2011 54 3661 3668 10.1021/jm101401a 21539312
100. Growth and pubertal development in nephropathic cystinosis. Winkler L, Offner G, Krull F, Brodehl J, Eur J Pediatr 1993 152 244 249 10.1007/BF01956154 8444253 (Pubitemid 23053254)
101. Azoospermia as a new feature of Fabry disease. Lacombe D, Germain DP, Papaxanthos-Roche A, Rev Med Interne 2010 31 Suppl 2 214 6 21211666
102. Late-onset cerebellar ataxia with hypogonadism and muscle coenzyme Q10 deficiency. Gironi M, Lamperti C, Nemni R, Moggio M, Comi G, Guerini FR, Ferrante P, Canal N, Naini A, Bresolin N, DiMauro S, Neurology 2004 62 818 820 15007142 (Pubitemid 38298968)
103. Endocrine abnormalities in mitochondrial myopathy with external ophthalmoplegia. Quade A, Zierz S, Klingmuller D, Clin Invest 1992 70 396 402
104. The syndrome of mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes presenting without stroke. Mosewich RK, Donat JR, DiMauro S, Ciafaloni E, Shanske S, Erasmus M, George D, Arch Neurol 1993 90 275 278 (Pubitemid 23069613)
105. Cognitive dysfunction and hypogonadotrophic hypogonadism in a Brazilian patient with mitochondrial neurogastrointestinal encephalomyopathy and a novel ECGF1 mutation. Carod-Artal FJ, Herrero MD, Lara MC, Lápez-Gallardo E, Ruiz-Pesini E, Martí R, Montoya J, Eur J Neurol 2007 14 581 585 10.1111/j.1468-1331.2007.01720.x 17437622 (Pubitemid 46587833)
106. Progressive external ophthalmoplegia and vision and hearing loss in a patient with mutations in POLG2 and OPA1. Ferraris S, Clark S, Garelli E, Davidzon G, Moore SA, Kardon RH, Bienstock RJ, Longley MJ, Mancuso M, Gutiérrez Ríos P, Hirano M, Copeland WC, DiMauro S, Arch Neurol 2008 65 125 131 10.1001/archneurol.2007.9 18195150
107. A patient with mitochondrial encephalomyopathy presenting gynecomastia with elevation of serum estriol level. Yamasaki R, Ohyagi Y, Kawajiri M, Shigeto H, Ikezoe K, Furuya H, Kira J, Rinsho Shinkeigaku 2004 44 291 295 15287512 (Pubitemid 38899653)
108. Estrogen-related receptor gamma is a key regulator of muscle mitochondrial activity and oxidative capacity. Rangwala SM, Wang X, Calvo JA, Lindsley L, Zhang Y, Deyneko G, Beaulieu V, Gao J, Turner G, Markovits J, J Biol Chem 2010 285 22619 22629 10.1074/jbc.M110.125401 20418374
109. The prevalence of polycystic ovaries in the hepatic glycogen storage diseases: its association with hyperinsulinism. Lee PJ, Patel A, Hindmarsh PC, Mowat AP, Leonard JV, Clin Endocrinol (Oxf) 1995 42 601 606 10.1111/j.1365-2265. 1995.tb02686.x
110. Evidence of polyglandular involvement in Niemann-Pick disease type B. Strisciuglio P, Di Maio S, Parenti G, Franzese A, Lubrano P, Mariano A, Andria G, Eur J Pediatr 1987 146 431 433 10.1007/BF00444957 2820735 (Pubitemid 17130867)
111. Primary adrenal insufficiency in a child with a mitochondrial DNA deletion. Bruno C, Minetti C, Tang Y, Magalhães PJ, Santorelli FM, Shanske S, Bado M, Cordone G, Gatti R, DiMauro S, J Inherit Metab Dis 1998 21 155 161 10.1023/A:1005347826664 9584267 (Pubitemid 28156176)
112. Identification of a large-scale mitochondrial deoxyribonucleic acid deletion in endocrinopathies and deafness: report of two unrelated cases with diabetes mellitus and adrenal insufficiency, respectively. Nicolino M, Ferlin T, Forest M, Godinot C, Carrier H, David M, Chatelain P, Mousson B, J Clin Endocrinol Metab 1997 82 3063 3067 10.1210/jc.82.9.3063 9284744 (Pubitemid 27385673)
113. Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome. Moraes CT, DiMauro S, Zeviani M, Lombes A, Shanske S, Miranda AF, Nakase H, Bonilla E, Werneck LC, Servidei S, et al. N Engl J Med 1989 320 1293 1299 10.1056/NEJM198905183202001 2541333 (Pubitemid 19140403)
114. Mitochondrial DNA deletion with Kearns Sayre syndrome in a child with Addison disease. Boles RG, Roe T, Senadheera D, Mahnovski V, Wong LJ, Eur J Pediatr 1998 157 643 647 10.1007/s004310050902 9727847 (Pubitemid 28381180)
115. Rare autosomal dominant POLG1 mutation in a family with metabolic strokes, posterior column spinal degeneration, and multi-endocrine disease. Hopkins SE, Somoza A, Gilbert DL, J Child Neurol 2010 25 752 756 10.1177/0883073809343313 19815814
116. Hyperkalemia in familial mitochondrial cytopathy. Shimizu J, Inatsu A, Oshima S, Shimizu E, Hirata H, Yasuda H, Kubota T, Clin Nephrol 2008 70 348 353 18826862
117. Hypoparathyroidism and insulin-dependent diabetes mellitus in a patient with Kearns-Sayre syndrome harbouring a mitochondrial DNA deletion. Shanti B, Silink M, Bhattacharya K, Howard NJ, Carpenter K, Fietz M, Clayton P, Christodoulou J, Clin Endocrinol (Oxf) 1996 45 637 641 10.1046/j.1365-2265.1996. 00856.x
118. The influence of Coenzyme Q10 on total serum calcium concentration in two patients with Kearns-Sayre Syndrome and hypoparathyroidism. Papadimitriou A, Hadjigeorgiou GM, Divari R, Papagalanis N, Comi G, Bresolin N, Neuromuscul Disord 1996 6 49 53 10.1016/0960-8966(95)00020-8 8845718
119. Mitochondrial encephalomyopathy and hypoparathyroidism associated with a duplication and a deletion of mitochondrial deoxyribonucleic acid. Tengan CH, Kiyomoto BH, Rocha MS, Tavares VL, Gabbai AA, Moraes CT, J Clin Endocrinol Metab 1998 83 125 129 10.1210/jc.83.1.125 9435428 (Pubitemid 28498322)
120. Hypogonadism, diabetes mellitus, hypothyroidism, hypoparathyroidism: incidence and prevalence related to iron overload and chelation therapy in patients with thalassaemia major followed from 1980 to 2007 in the Ferrara Centre. Gamberini MR, De Sanctis V, Gilli G, Pediatr Endocrinol Rev 2008 6 Suppl 1 158 169 19337172
121. A case of Wilson's disease associated with hypoparathyroidism and amenorrhea. Okada M, Higashi K, Enomoto S, Fujii Y, Yamane H, Tsujiuti K, Tanimoto S, Itoh H, Nishioka S, Yasui M, Tanaka T, Nippon Shokakibyo Gakkai Zasshi 1998 95 445 449 9621702 (Pubitemid 28234975)
122. Fabry's disease and hypoparathyroidism. Misery L, Gregoire M, Prieur F, Froissart R, Guffon N, Maitre S, Fond L, Denis L, Perrot JL, Cambazard F, Ann Med Interne (Paris) 2002 153 283 285 (Pubitemid 34879273)
123. Hypoparathyroidism in a patient with long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency caused by the G1528C mutation. Tyni T, Rapola J, Palotie A, Pihko H, J Pediatr 1997 131 766 768 10.1016/S0022-3476(97)70111-2 9403664 (Pubitemid 27524863)
124. Hypoketotic hypoglycemia with myolysis and hypoparathyroidism: an unusual association in medium chain acyl-CoA desydrogenase deficiency (MCADD). Baruteau J, Levade T, Redonnet-Vernhet I, Mesli S, Bloom MC, Broué P, J Pediatr Endocrinol Metab 2009 22 1175 1177 10.1515/JPEM.2009.22.12.1175 20333879
125. Central diabetes insipidus and hypothalamic hypothyroidism associated with aceruloplasminemia. Watanabe M, Asai C, Ishikawa K, Kiyota A, Terada T, Kono S, Miyajima H, Okumura A, Intern Med 2010 49 1581 1585 10.2169/ internalmedicine.49.3508 20686294
126. Hypopituitarism in primary haemochromatosis, recovery after iron depletion. Gama R, Smith MJ, Wright J, Marks V, Postgrad Med J 1995 71 297 298 10.1136/pgmj.71.835.297 7596937
127. Multiple endocrine abnormalities in a child with Blackfan-Diamond anemia and hemochromatosis Significant improvement of growth velocity and predicted adult height following growth hormone treatment despite liver damage. Lanes R, Muller A, Palacios A, J Pediatr Endocrinol Metab 2000 13 325 328 10.1515/JPEM.2000.13.3.325 10714760 (Pubitemid 30163759)
128. Growth in treated classical galactosemia patients. Panis B, Gerver WJ, Rubio-Gozalbo ME, Eur J Pediatr 2007 166 443 446 10.1007/s00431-006-0255-4 17024348 (Pubitemid 46450478)
129. Growth hormone deficiency in two siblings with Alström syndrome. Alter CA, Moshang T Jr, Am J Dis Child 1993 147 97 99 8418611 (Pubitemid 23026887)
130. Rare case of Alstrom syndrome without obesity and with short stature, diagnosed in adulthood. Koç E, Bayrak G, Suher M, Ensari C, Aktas D, Ensari A, Nephrology (Carlton) 2006 11 81 84 10.1111/j.1440-1797.2006.00443.x
131. Characterization of the IGF system in 15 patients with Alström syndrome. Maffei P, Boschetti M, Marshall JD, Paisey RB, Beck S, Resmini E, Collin GB, Naggert JK, Milan G, Vettor R, Minuto F, Sicolo N, Barreca A, Clin Endocrinol (Oxf) 2007 66 269 275 10.1111/j.1365-2265.2007.02721.x (Pubitemid 46096148)
132. Bone metabolism in oxalosis: a single-center study using new imaging techniques and biomarkers. Bacchetta J, Fargue S, Boutroy S, Basmaison O, Vilayphiou N, Plotton I, Guebre-Egziabher F, Dohin B, Kohler R, Cochat P, Pediatr Nephrol 2010 25 1081 1088 10.1007/s00467-010-1453-x 20213134